Bioventus Inc.BVSNASDAQ
Loading
Operating Margin Over TimeExpanding
Percentile Rank100
5Y CAGR+8.7%
Studio
Year-over-Year Change

Operating income as a percentage of revenue

5Y CAGR
+8.7%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM10.04%+580.7%
2024-2.09%+86.9%
2023-15.95%+51.2%
2022-32.66%-1266.7%
20212.80%-57.7%
20206.61%-27.9%
20199.17%+14.8%
20187.99%-13.6%
20179.25%+70.6%
20165.42%-